149 related articles for article (PubMed ID: 1757609)
1. A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus.
Brunner N; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1160-3. PubMed ID: 1757609
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus.
Datz B; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1157-60. PubMed ID: 1757608
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasis.
Goldberg B; Hartdegen R; Presbury D; Smith EH; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1145-8. PubMed ID: 1757605
[TBL] [Abstract][Full Text] [Related]
4. A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasis.
Blum G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1153-6. PubMed ID: 1757607
[TBL] [Abstract][Full Text] [Related]
5. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis.
Herz G; Blum G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1166-9. PubMed ID: 1757611
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Mensing H; Korsukewitz G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
[TBL] [Abstract][Full Text] [Related]
7. A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses.
Guzzo CA; Weiss JS; Mogavero HS; Ellis CN; Zaias N; Lowe NJ; Kerdel FA; Milbauer JJ; Bernhard JD; Whitmore C
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1179-83. PubMed ID: 1757614
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis.
Yawalkar SJ; Schwerzmann L
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1163-6. PubMed ID: 1757610
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of halobetasol propionate ointment in the treatment of plaque psoriasis: report on two double-blind, vehicle-controlled studies.
Bernhard J; Whitmore C; Guzzo C; Kantor I; Kalb RE; Ellis C; Urbach F; Schwartzel EH; Gibson JR
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1170-4. PubMed ID: 1757612
[TBL] [Abstract][Full Text] [Related]
10. Double-blind bilateral paired comparison of 0.05% halobetasol propionate cream and its vehicle in patients with chronic atopic dermatitis and other eczematous dermatoses.
Kantor I; Cook PR; Cullen SI; Willis I; Gibson JR; Stanfield JW
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1184-6. PubMed ID: 1757615
[TBL] [Abstract][Full Text] [Related]
11. Diflucortolone valerate ointment with and without occlusion in lichen simplex chronicus.
Geraldez MC; Carreon-Gavino M; Hoppe G; Costales A
Int J Dermatol; 1989 Nov; 28(9):603-4. PubMed ID: 2583907
[No Abstract] [Full Text] [Related]
12. A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment.
Wendt H; Mugglestone CJ; Wiseman RA
Br J Dermatol; 1978 Oct; 99(4):411-6. PubMed ID: 361059
[TBL] [Abstract][Full Text] [Related]
13. Dermatopharmacologic investigations of halobetasol propionate in comparison with clobetasol 17-propionate.
Yawalkar S; Wiesenberg-Boettcher I; Gibson JR; Siskin SB; Pignat W
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1137-44. PubMed ID: 1757603
[TBL] [Abstract][Full Text] [Related]
14. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the potencies of several diluted and undiluted corticosteroid preparations using the vasoconstrictor assay.
Kirsch J; Gibson JR; Darley CR; Burke CA
Dermatologica; 1983; 167(3):138-41. PubMed ID: 6195026
[TBL] [Abstract][Full Text] [Related]
16. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.
Lebwohl M; Siskin SB; Epinette W; Breneman D; Funicella T; Kalb R; Moore J
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):268-9. PubMed ID: 8708035
[No Abstract] [Full Text] [Related]
17. Comparative toxicity study of hydrocortisone 17-butyrate 21-propionate (HBP) ointment and other topical corticosteroids in rats.
Kimura M; Tarumoto Y; Nakane S; Otomo S
Drugs Exp Clin Res; 1986; 12(8):643-52. PubMed ID: 3757761
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, vehicle-controlled paired comparison of halobetasol propionate cream on patients with plaque psoriasis.
Katz HI; Gross E; Buxman M; Prawer SE; Schwartzel EH; Gibson JR
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1175-8. PubMed ID: 1757613
[TBL] [Abstract][Full Text] [Related]
19. Plasma cortisol values after topical application of diflucortolone valerate (0.3%) or clobetasol propionate (0.05%) in psoriatic patients.
Keczkes K; Teasdale P; Wiseman RA; Mugglestone CJ
Br J Dermatol; 1978 Oct; 99(4):417-20. PubMed ID: 361060
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and topical therapy.
Lebwohl M
Cutis; 2002 Nov; 70(5 Suppl):5-8. PubMed ID: 12467332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
